Dare Bioscience (DARE) EPS (Basic) Growth (5y) (2018 - 2026)
Dare Bioscience (DARE) EPS (Basic) Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.05 Bn | 131.20 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 78.00 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.49 Bn | 60.31 Bn | 1.37 Bn |
| 4 | Moderna | 56.79 Bn | 51.65 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.14 Bn | 37.05 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.27 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.71 Bn | 9.32 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.51 Bn | - |
| 10 | Dare Bioscience | 12.39 Mn | -230,742.75 | -132,343.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 34.73% |
| Dec 31, 2025 | 46.58% |
| Sep 30, 2025 | 30.93% |
| Jun 30, 2025 | 26.85% |
| Mar 31, 2025 | 18.40% |
| Dec 31, 2024 | 26.72% |
| Sep 30, 2024 | 25.10% |
| Jun 30, 2024 | 23.92% |
| Mar 31, 2024 | 25.83% |
| Dec 31, 2023 | 18.06% |
| Sep 30, 2023 | 16.56% |
| Jun 30, 2023 | 19.62% |
| Mar 31, 2023 | 36.12% |
| Dec 31, 2022 | 41.82% |
| Sep 30, 2022 | 24.04% |
| Jun 30, 2022 | -49.54% |
| Mar 31, 2022 | 21.79% |
| Dec 31, 2021 | 7.12% |
| Sep 30, 2021 | 21.08% |
| Jun 30, 2020 | 40.94% |